Replication of Real-World Evidence in Oncology Using Electronic Health Record Data Extracted by Machine Learning

Author:

Benedum Corey M.1ORCID,Sondhi Arjun1,Fidyk Erin1,Cohen Aaron B.12,Nemeth Sheila1,Adamson Blythe13ORCID,Estévez Melissa1ORCID,Bozkurt Selen1ORCID

Affiliation:

1. Flatiron Health, Inc., 233 Spring Street, New York, NY 10003, USA

2. Department of Medicine, NYU Grossman School of Medicine, New York, NY 10016, USA

3. Comparative Health Outcomes, Policy and Economics (CHOICE) Institute, University of Washington, Seattle, WA 98195, USA

Abstract

Meaningful real-world evidence (RWE) generation requires unstructured data found in electronic health records (EHRs) which are often missing from administrative claims; however, obtaining relevant data from unstructured EHR sources is resource-intensive. In response, researchers are using natural language processing (NLP) with machine learning (ML) techniques (i.e., ML extraction) to extract real-world data (RWD) at scale. This study assessed the quality and fitness-for-use of EHR-derived oncology data curated using NLP with ML as compared to the reference standard of expert abstraction. Using a sample of 186,313 patients with lung cancer from a nationwide EHR-derived de-identified database, we performed a series of replication analyses demonstrating some common analyses conducted in retrospective observational research with complex EHR-derived data to generate evidence. Eligible patients were selected into biomarker- and treatment-defined cohorts, first with expert-abstracted then with ML-extracted data. We utilized the biomarker- and treatment-defined cohorts to perform analyses related to biomarker-associated survival and treatment comparative effectiveness, respectively. Across all analyses, the results differed by less than 8% between the data curation methods, and similar conclusions were reached. These results highlight that high-performance ML-extracted variables trained on expert-abstracted data can achieve similar results as when using abstracted data, unlocking the ability to perform oncology research at scale.

Funder

Flatiron Health, Inc.

Publisher

MDPI AG

Subject

Cancer Research,Oncology

Reference41 articles.

1. Assessing function of electronic health records for real-world data generation;Guinn;BMJ Evid.-Based Med.,2019

2. Congressional intent for the HITECH Act;Stark;Am. J. Manag. Care,2010

3. An Exploratory Analysis of Real-World End Points for Assessing Outcomes Among Immunotherapy-Treated Patients with Advanced Non–Small-Cell Lung Cancer;Stewart;JCO Clin. Cancer Inform.,2019

4. Zhang, J., Symons, J., Agapow, P., Teo, J.T., Paxton, C.A., Abdi, J., Mattie, H., Davie, C., Torres, A.Z., and Folarin, A. (2022). Best practices in the real-world data life cycle. PLoS Digit. Health, 1.

5. Birnbaum, B., Nussbaum, N., Seidl-Rathkopf, K., Agrawal, M., Estevez, M., Estola, E., Haimson, J., He, L., Larson, P., and Richardson, P. (2020). Model-assisted cohort selection with bias analysis for generating large-scale cohorts from the EHR for oncology research. arXiv.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3